"Naproxen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout.
| Descriptor ID |
D009288
|
| MeSH Number(s) |
D02.455.426.559.847.638.472.500 D04.615.638.472.450
|
| Concept/Terms |
Naproxen Sodium- Naproxen Sodium
- Sodium, Naproxen
- Sodium Naproxenate
- Naproxenate, Sodium
|
Below are MeSH descriptors whose meaning is more general than "Naproxen".
Below are MeSH descriptors whose meaning is more specific than "Naproxen".
This graph shows the total number of publications written about "Naproxen" by people in this website by year, and whether "Naproxen" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2017 | 2 | 2 | 4 |
| 2018 | 1 | 1 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Naproxen" by people in Profiles.
-
Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus. Molecules. 2021 Apr 29; 26(9).
-
In Vitro Assessment of the Antiviral Activity of Ketotifen, Indomethacin and Naproxen, Alone and in Combination, against SARS-CoV-2. Viruses. 2021 03 26; 13(4).
-
The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study. Daru. 2020 Dec; 28(2):507-516.
-
Effect of tadalafil on reduction of necrosis in the ischemic zone in a rat comb burn model. Burns. 2018 09; 44(6):1427-1432.
-
Thromboxane inhibition during concurrent therapy with low-dose aspirin and over-the-counter naproxen sodium. J Thromb Thrombolysis. 2018 Jan; 45(1):18-26.
-
Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial. Eur Heart J. 2017 Nov 21; 38(44):3282-3292.
-
Amphiphilic naproxen prodrugs: differential scanning calorimetry study on their interaction with phospholipid bilayers. J Pharm Pharmacol. 2017 Sep; 69(9):1091-1098.
-
NSAIDs and cardiac arrest: Non-steroidal anti-inflammatory drug use is associated with increased risk of Out-of-hospital Cardiac Arrest: A nationwide Case-Time-Control study. Eur Heart J. 2017 06 14; 38(23):1788-1789.
-
Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial. Lancet. 2017 Jun 17; 389(10087):2375-2382.
-
Lack of cardioprotective effect of naproxen. Arch Intern Med. 2002 Dec 9-23; 162(22):2637; author reply 2638-9.